Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Deals
Biotech
GSK inks model deal in $50M bet on Noetik's cancer AI platform
GSK has committed $50 million in upfront capital and near-term milestones to secure a license to two cancer research foundation models from Noetik.
Nick Paul Taylor
Jan 8, 2026 10:30am
Foresee offloads clinical-stage MMP-12 inhibitors in $584M deal
Jan 8, 2026 7:45am
Lilly buys inflammation biotech Ventyx for $1.2B
Jan 8, 2026 7:01am
Pharma's 'urgent need for reinvention': PwC's call to action
Jan 8, 2026 6:00am
InduPro nabs 2nd Big Pharma deal with $950M Lilly pact
Jan 7, 2026 3:52pm
Amgen dances with Disco in $618M cancer target pact
Jan 7, 2026 10:15am
